Elanco Animal Health
ELAN
438 hedge funds and large institutions have $9.24B invested in Elanco Animal Health in 2022 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 164 increasing their positions, 145 reducing their positions, and 85 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 145
0.72% less ownership
Funds ownership: 99.99% → 99.27% (-0.72%)
7% less funds holding
Funds holding: 472 → 438 (-34)
18% less call options, than puts
Call options by funds: $13.6M | Put options by funds: $16.5M
25% less capital invested
Capital invested by funds: $12.4B → $9.24B (-$3.11B)
28% less first-time investments, than exits
New positions opened: 61 | Existing positions closed: 85
60% less funds holding in top 10
Funds holding in top 10: 10 → 4 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$488M |
| 2 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
+$83.7M |
| 3 |
Morgan Stanley
New York
|
+$59.7M |
| 4 |
BlackRock
New York
|
+$49.5M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$292M |
| 2 |
VIP
Vantage Investment Partners
Kansas City,
Missouri
|
-$104M |
| 3 |
Bank of New York Mellon
New York
|
-$76.3M |
| 4 |
SIG
Senator Investment Group
New York
|
-$65.2M |
| 5 |
SC
Sculptor Capital
New York
|
-$59.7M |
ELAN Hedge Fund Activity: Q2 2022 in Review
438 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2022, worth a combined $9.24B — down 25% from $12.4B a quarter earlier.
Sellers outnumbered buyers: 85 funds closed out of ELAN and 61 opened new positions — a net loss of 24 holders — while 145 trimmed existing stakes and 164 added.
The largest buyer was Dodge & Cox, adding an estimated $488M. The largest seller was T. Rowe Price Associates, cutting an estimated $292M.
- 438 institutional investors held Elanco Animal Health (ELAN) as of Q2 2022, down from 472 in Q1 2022.
- Funds reported $9.24B of Elanco Animal Health stock for Q2 2022, down 25% quarter-over-quarter.
- 61 funds opened new Elanco Animal Health positions in Q2 2022 and 85 closed out, a net change of -24 holders.
- The largest Elanco Animal Health buyer in Q2 2022 was Dodge & Cox, an estimated $488M added.
- The largest Elanco Animal Health seller in Q2 2022 was T. Rowe Price Associates, an estimated $292M sold.
Based on aggregated 13F filings for Q2 2022.